Einas A Osman1, Nagwa E El-Amin2, Leena L Al-Hassan3, Maowia Mukhtar4. 1. Faculty of Medical Laboratories, Microbiology Department, Ibn Sina University, Algerief West, Khartoum, Sudan; Bioscience Research Institute, Ibn Sina University, Khartoum, Sudan. 2. Department of Pathology, College of Medicine, Qassim University, Saudi Arabia. 3. Department of Global Health and Infection, Brighton and Sussex Medical School, BN1 9PX, UK. Electronic address: l.al-hassan@bsms.ac.uk. 4. Bioscience Research Institute, Ibn Sina University, Khartoum, Sudan; Institute of Endemic Diseases, University of Khartoum, Sudan.
Abstract
OBJECTIVES: Multidrug-resistant (MDR) Klebsiella pneumoniae is increasing worldwide with poorly characterised epidemiology in many parts of the world, particularly in Africa. This study aimed to investigate the molecular epidemiology of K. pneumoniae, to identify the diversity of sequence types (ST), and to detect carbapenem resistance genes in major regional hospitals in Khartoum, Sudan. METHODS: Klebsiella pneumoniae isolates (n = 117) were cultured from four hospitals in Khartoum, from April 2015 to October 2016. The isolates were characterised by sequencing of 16S-23S rDNA internal transcribed spacer (ITS) region. Molecular epidemiology was determined by multilocus sequence typing (MLST), and analysed by maximum likelihood phylogeny (PhyML). Antimicrobial susceptibility was determined by disk diffusion. Isolates phenotypically resistant to carbapenem were screened for carbapenemase genes: blaNDM, blaOXA48, blaIMP, blaVIM and blaGES by PCR. RESULTS: ITS sequencing confirmed the 117 isolates as K. pneumoniae. MLST revealed 52 different STs grouped in four distinct clusters by PhyML. All isolates were MDR, and carbapenemase-producing K. pneumoniae (CP-KP) isolates accounted for 44/117 (37.6%) mostly harbouring blaNDM (28/44) and blaOXA-48 (7/44), with several isolates harbouring multiple genes. CONCLUSION: MDR and CP-KP K. pneumoniae is widespread in Khartoum hospitals, with a diverse population of 52 STs clustering in four major lineages. There is an urgent need for systematic epidemiological studies of drug-resistant infections across all healthcare institutions in Sudan to inform local infection prevention and control strategies.
OBJECTIVES: Multidrug-resistant (MDR) Klebsiella pneumoniae is increasing worldwide with poorly characterised epidemiology in many parts of the world, particularly in Africa. This study aimed to investigate the molecular epidemiology of K. pneumoniae, to identify the diversity of sequence types (ST), and to detect carbapenem resistance genes in major regional hospitals in Khartoum, Sudan. METHODS:Klebsiella pneumoniae isolates (n = 117) were cultured from four hospitals in Khartoum, from April 2015 to October 2016. The isolates were characterised by sequencing of 16S-23S rDNA internal transcribed spacer (ITS) region. Molecular epidemiology was determined by multilocus sequence typing (MLST), and analysed by maximum likelihood phylogeny (PhyML). Antimicrobial susceptibility was determined by disk diffusion. Isolates phenotypically resistant to carbapenem were screened for carbapenemase genes: blaNDM, blaOXA48, blaIMP, blaVIM and blaGES by PCR. RESULTS: ITS sequencing confirmed the 117 isolates as K. pneumoniae. MLST revealed 52 different STs grouped in four distinct clusters by PhyML. All isolates were MDR, and carbapenemase-producing K. pneumoniae (CP-KP) isolates accounted for 44/117 (37.6%) mostly harbouring blaNDM (28/44) and blaOXA-48 (7/44), with several isolates harbouring multiple genes. CONCLUSION: MDR and CP-KP K. pneumoniae is widespread in Khartoum hospitals, with a diverse population of 52 STs clustering in four major lineages. There is an urgent need for systematic epidemiological studies of drug-resistant infections across all healthcare institutions in Sudan to inform local infection prevention and control strategies.
Authors: Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope Journal: Antimicrob Agents Chemother Date: 2022-07-20 Impact factor: 5.938
Authors: Borel Bisso Ndezo; Christian Ramsès Tokam Kuaté; Jean Paul Dzoyem Journal: Can J Infect Dis Med Microbiol Date: 2021-11-08 Impact factor: 2.471
Authors: Borel Ndezo Bisso; Christian Ramsès Tokam Kuaté; Nathalie Boulens; Eric Allémann; Florence Delie; Jean Paul Dzoyem Journal: Evid Based Complement Alternat Med Date: 2022-07-21 Impact factor: 2.650